NIH-funded research NIH-funded research

Improving research on Sickle Cell Disease and related health issues in Uganda.

Official title: Enhancing Research capacity for Sickle Cell Disease and related NCDs across the Lifespan in Uganda. ''Enrich Project''

Funded at Makerere University College of Health Sciences · NIH-11032041 · Data updated 2026-11-12

This study is all about helping kids in Uganda who have Sickle Cell Disease by training a team of researchers to learn more about how it affects their health and finding better ways to support them.

More Sickle Cell Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMakerere University College of Health Sciences
NIH-funded
Lab location1 site (Kampala, Uganda)
Project startApril 1, 2023
Project endFebruary 29, 2028
Funding year2025
Award (this year)$245,057
NIH project number5D43TW012466-03
Project IDNIH-11032041 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Sickle Cell Disease, particularly children and adults living in Uganda.

Less likely to help

Patients with Sickle Cell Disease residing outside of Uganda or those without access to the healthcare system in Uganda may not benefit from this research.

What this research studies

This research focuses on enhancing the capacity to study Sickle Cell Disease (SCD) and related non-communicable diseases (NCDs) in Uganda, where SCD significantly impacts children's health. The project aims to train a multidisciplinary team of researchers to better understand and address the health challenges associated with SCD, including its effects on the brain, kidneys, and overall quality of life. By building local research expertise, the project seeks to develop effective interventions and improve health outcomes for affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to improved health outcomes and quality of life for patients with Sickle Cell Disease in Uganda.

How similar studies have gone: Previous research has shown promising results in enhancing health outcomes for Sickle Cell Disease patients through improved local research capacity, indicating that this approach has potential for success.

Where this research is happening

  • Makerere University College of Health Sciences
    Kampala, Uganda
    Active

Researchers

  • Principal investigator: Kiguli, Sarah — Makerere University College of Health Sciences
  • Study coordinator: Kiguli, Sarah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.